Found: 35
Select item for more details and to access through your institution.
Patients assigned to VGPR, PR, and SD in the IMWG response category are composed of heterogeneous population when assessed by the heavy/light chain assay.
- Published in:
- 2019
- By:
- Publication type:
- letter
Tandem autologous stem cell transplantation in elderly patients with myeloma: A multicenter retrospective analysis.
- Published in:
- European Journal of Haematology, 2023, v. 110, n. 4, p. 444, doi. 10.1111/ejh.13922
- By:
- Publication type:
- Article
Outcomes of ixazomib/lenalidomide/dexamethasone for multiple myeloma: A multicenter retrospective analysis.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 4, p. 555, doi. 10.1111/ejh.13586
- By:
- Publication type:
- Article
Clinical impacts of severe thrombocytopenia in the first cycle of azacitidine monotherapy and cytogenetics in patients with myelodysplastic syndrome: The Kyoto Conditional Survival Scoring System.
- Published in:
- Oncology Letters, 2024, v. 27, n. 2, p. N.PAG, doi. 10.3892/ol.2023.14193
- By:
- Publication type:
- Article
Non-T-cell-depleted HLA-haploidentical stem cell transplantation after reduced-intensity conditioning in advanced haematological malignancies based on feto-maternal microchimerism.
- Published in:
- 2004
- By:
- Publication type:
- Letter
Interleukin 8 is not involved in G-CSF-induced peripheral blood stem cell transplantation.
- Published in:
- British Journal of Haematology, 2002, v. 117, n. 3, p. 770, doi. 10.1046/j.1365-2141.2002.34903.x
- By:
- Publication type:
- Article
Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12).
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 8, p. 966, doi. 10.1007/s10147-019-01436-8
- By:
- Publication type:
- Article
Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma Forum.
- Published in:
- EJHaem, 2021, v. 2, n. 4, p. 765, doi. 10.1002/jha2.284
- By:
- Publication type:
- Article
The serum level of plasmin‐alpha2 plasmin inhibitor complex (PIC) is useful for differentiating cardiac light chain amyloidosis from transthyretin amyloidosis.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 6, p. 1209, doi. 10.1111/bjh.18976
- By:
- Publication type:
- Article
Primary analysis of a prospective cohort study of Japanese patients with plasma cell neoplasms in the novel drug era (2016–2021).
- Published in:
- International Journal of Hematology, 2024, v. 119, n. 6, p. 707, doi. 10.1007/s12185-024-03754-8
- By:
- Publication type:
- Article
Real-world data on induction therapy in patients with transplant-ineligible newly diagnosed multiple myeloma: retrospective analysis of 598 cases from Kansai Myeloma Forum.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 5, p. 609, doi. 10.1007/s12185-023-03653-4
- By:
- Publication type:
- Article
A retrospective analysis of clinical features and treatment outcome in 21 patients with immunoglobulin M-related light-chain amyloidosis in Japan: a study from the Amyloidosis Research Committee.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 4, p. 443, doi. 10.1007/s12185-023-03647-2
- By:
- Publication type:
- Article
Real-world practice-based prognostic model for higher-risk myelodysplastic syndromes treated with azacitidine monotherapy: The Kyoto prognostic scoring system.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 3, p. 323, doi. 10.1007/s12185-023-03627-6
- By:
- Publication type:
- Article
Retrospective analysis of plasmacytoma in Kansai Myeloma Forum Registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Retrospective multi-center study of Adolescent and Young Adult (AYA) Multiple Myeloma in Kansai Myeloma Forum registry.
- Published in:
- International Journal of Hematology, 2020, v. 112, n. 4, p. 435, doi. 10.1007/s12185-020-02996-6
- By:
- Publication type:
- Article
A retrospective analysis of treatment outcomes in 45 patients with cardiac light-chain amyloidosis: a single-center experience in Japan.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Combined rituximab, bendamustine, and dexamethasone chemotherapy for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: a multicenter phase II study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction to: A phase II study of lenalidomide consolidation and maintenance therapy after autologous PBSCT in patients with multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- corrected article
Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Phase 1 study of bortezomib in combination with melphalan and dexamethasone in Japanese patients with relapsed AL amyloidosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
The longitudinal analysis of large granular lymphocytosis in patients with Philadelphia chromosome-positive leukemia treated with dasatinib.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma.
- Published in:
- International Journal of Hematology, 2015, v. 101, n. 1, p. 37, doi. 10.1007/s12185-014-1696-6
- By:
- Publication type:
- Article
Serial measurement of free light chain detects poor response to therapy early in three patients with multiple myeloma who have measurable M-proteins.
- Published in:
- 2012
- By:
- Publication type:
- Report
Combination Therapy with Thalidomide, Incadronate, and Dexamethasone for Relapsed or Refractory Multiple Myeloma.
- Published in:
- 2005
- By:
- Publication type:
- journal article
The unbalanced chromosomal translocation der(15)t(1;15)(q21;p13) in multiple myeloma.
- Published in:
- 2005
- By:
- Publication type:
- case study
Plasmacytoma of the urinary bladder in a renal transplant recipient.
- Published in:
- 2005
- By:
- Publication type:
- journal article
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2024, v. 73, n. 7, p. 1, doi. 10.1007/s00262-024-03711-8
- By:
- Publication type:
- Article
Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-32426-6
- By:
- Publication type:
- Article
Anti‐CD38 antibody isatuximab monotherapy for Japanese individuals with relapsed/refractory multiple myeloma: An update of the phase 1/2 ISLANDs study.
- Published in:
- Hematological Oncology, 2023, v. 41, n. 3, p. 442, doi. 10.1002/hon.3105
- By:
- Publication type:
- Article
Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma.
- Published in:
- Hematological Oncology, 2021, v. 39, n. 3, p. 349, doi. 10.1002/hon.2863
- By:
- Publication type:
- Article
Monocyte or white blood cell counts and β<sub>2</sub> microglobulin predict the durable efficacy of daratumumab with lenalidomide.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221142487
- By:
- Publication type:
- Article
Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis.
- Published in:
- Therapeutic Advances in Hematology, 2022, v. 13, p. 1, doi. 10.1177/20406207221104584
- By:
- Publication type:
- Article
Is splenectomy a contraindication for patients with myelodysplastic syndromes complicated by splenomegaly?
- Published in:
- 2006
- By:
- Publication type:
- Letter
Improved survival of multiple myeloma patients treated with autologous transplantation in the modern era of new medicine.
- Published in:
- Cancer Science, 2021, v. 112, n. 12, p. 5034, doi. 10.1111/cas.15163
- By:
- Publication type:
- Article